Generate a tailored SOP for Dr. Hristo Svilenov. Improve your application with a focused, well-structured draft.
Prof. Hristo Svilenov conducts research in the field of biopharmaceutical technology, with a main focus on recombinant therapeutic proteins produced in mammalian cell culture. He utilizes orthogonal analytical methods to provide mechanistic insights into novel proteins and bioprocesses to support the development of new medicines. Prof. Svilenov studied Pharmacy at the Medical University of Sofia and defended his PhD thesis in Pharmaceutical Technology at Ludwig Maximilian University of Munich in 2019. He experienced a post-doctoral stay at the Technical University of Munich from 2020 to 2021 and was subsequently appointed as an Associate Professor of Biopharmaceutical Production Technology at Ghent University in Belgium. In 2024, he was appointed professor of Biopharmaceutical Technology at the TUM School of Life Sciences. His work is characterized by a commitment to advancing the field through innovation and research excellence.